As we close out the new year, it has been one to remember. Or, possibly, better to forget. In my own case, we had planned on having friends over for the evening. But, unfortunately, one was exposed to COVID, and then we found out late this morning that we had been exposed to COVID as well. This far, all the tests are negative—so wish us luck. But the risks are definitely on my mind at the moment.

It has been going on two months since we last took a detailed look at the pandemic. Of course, a lot has happened since then. Between the winter wave of Delta, the emergence of Omicron, and the rising hospitalizations putting regional health care systems at risk again, there is a concern as to whether we are entering a third pandemic. I don’t think so, at this point. But let’s take a detailed look at where we are now and at the real question going forward—how bad will this get?

Over the past month, we have done a couple of posts about ESG investing, notably from my younger colleagues. I have gotten—not pushback, really—but comments to that effect both on the blog and elsewhere. The feeling seems to be, at least to some extent, that ESG is different from what prior generations, which is to say old people (which is to say me), have looked at and that somehow this represents a change.

My colleague Sam Millette, manager, fixed income on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Market Risk Update. Thanks for the assist, Sam!

My colleague Sam Millette, manager, fixed income on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Economic Risk Factor Update. Thanks for the assist, Sam!

November was a solid month for the economy but difficult in terms of both the medical news and financial markets. After a strong October, the Fed announced plans to start tightening monetary policy. Then we heard about a new variant of COVID-19. By month-end, the combined news pulled the markets down from midmonth gains to much more mixed results.

After a strong October, November saw generally weak performance in the markets. In the U.S., the Nasdaq showed a small gain, but the S&P and the Dow were down. These results were driven by the emergence of the Omicron variant and the Fed’s announcement that it would start to normalize monetary policy. Still, hiring for October was healthy, and layoffs dropped to pre-pandemic levels in November.

Once again, we have some volatility in the financial markets. With the appearance of the Omicron variant of the COVID virus, stocks have pulled back. This has caused all sorts of speculation about the resurgence of the pandemic, the derailing of the economy, and more significant downturns in the market. It’s time for a deep breath, as always, and a determination of what is—not what could or might be—happening.

It has been proven that being grateful is one of the best ways to make your life better—to be both happier and more successful. Here on the blog, I try to focus on gratitude a couple of times a year, although I notice that I have not done so through 2020 or really 2021. Perhaps that’s understandable, with the pandemic, but still misguided. Despite the real problems and concerns, I have much to be grateful for, and I hope you do as well. So let’s take Thanksgiving as the perfect opportunity to remember that.

I have always rather disliked the saying, “What gets measured gets managed.” On one hand, it is a truism. On the other hand, it is misleading in many ways. Today’s issue, inflation, is a great example. How we manage it depends very closely on how we measure it, which is quite true. But it begs the question as to how we should measure it. I might rephrase the saying, in this case, as, “What gets appropriately measured gets effectively managed.” This phrasing still has issues but is much closer to what we actually need to do. Beyond this, we start to get into pedantry, if we are not already there.